OVID icon

Ovid Therapeutics

69 hedge funds and large institutions have $135M invested in Ovid Therapeutics in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 21 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
69
Holders Change
+9
Holders Change %
+15%
% of All Funds
1.09%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
23
Increased
21
Reduced
15
Closed
14
Calls
$116K
Puts
$5K
Net Calls
+$111K
Net Calls Change
+$87K
Name Holding Trade Value Shares
Change
Shares
Change %
Balyasny Asset Management
76
Balyasny Asset Management
Illinois
-$62.1K -24,056 Closed
CC
77
Cannell Capital
Wyoming
-$58.4K -22,620 Closed
VF
78
Virtu Financial
New York
-$46K -17,892 Closed
Mariner
79
Mariner
Kansas
-$35K -13,500 Closed
Squarepoint
80
Squarepoint
New York
-$29.1K -11,271 Closed
PMEF
81
Point72 Middle East FZE
United Arab Emirates
-$15.5K -5,993 Closed
CSS
82
Cubist Systematic Strategies
Connecticut
-$13.3K -5,155 Closed
Simplex Trading
83
Simplex Trading
Illinois
-$1K -422 Closed
Man Group
84
Man Group
United Kingdom
-$71.6K